Advancing Technologies for Faster Detection. Smarter Response. Greater Resilience.
Chemical and biological threats are becoming more diverse, more sophisticated, and increasingly difficult to detect before they impact military operations, critical infrastructure, public health, or civilian populations. Emerging pathogens, engineered biological agents, toxic industrial chemicals, and novel chemical warfare agents demand faster detection, smarter analysis, and more resilient protective capabilities.
The Chem-Bio Threat Detection Innovation Challenge identified innovative technologies that strengthen detection, characterization, protection, and response across the full spectrum of chemical and biological threats. These scalable, dual-use solutions improve preparedness, accelerate operational decision-making, and enhance resilience across defense, homeland security, public health, and emergency response missions.
Ten (10) finalists presented their technology solutions live at Defense TechConnect Innovation Summit before government agencies, industry leaders, investors, and commercialization partners in September of 2026. Learn more about Challenge outcomes by downloading the case study below.
REVIEW PANELISTS
Dr. Deborah Hemingway
Managing Partner, Ecphora Capital
Jay Reckard
President, Reckard Consulting
Dr. Mike Stebbins
Sr. Vice President, Medical and Threat Countermeasures Division, Advanced Technology International (ATI)
Brannan Villee
Division Director, S&T Directorate, U.S. Department of Homeland Security (DHS)
Justin Yang
Co-Founder, DMV Bio
WINNERS
First Place
$25,000
PHC Global
SECOND PLACE
$15,000
Zeteo Tech
THIRD PLACE
$10,000
Probius
FINALISTS
- Alakai Defense Systems
- Ave Maria Biotech
- CAS, a Division of the American Chemical Society
- Claryx, Inc.
- Guild Associates, Inc.
- ReliOx Corporation
- Skyplate Technology LLC